Pearl River Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,519
Closed -$3.92M 221
2024
Q2
$3.92M Buy
9,519
+2,031
+27% +$804K 0.62% 46
2024
Q1
$3.03M Buy
7,488
+2,583
+53% +$908K 0.48% 54
2023
Q4
$1.5M Sell
4,905
-171
-3% -$46.2K 0.24% 127
2023
Q3
$1.23M Sell
5,076
-1,177
-19% -$301K 0.19% 181
2023
Q2
$1.5M Buy
6,253
+644
+11% +$134K 0.24% 137
2023
Q1
$1.05M Buy
5,609
+1,041
+23% +$215K 0.17% 194
2022
Q4
$970K Sell
4,568
-335
-7% -$66.9K 0.16% 200
2022
Q3
$771K Buy
+4,903
New +$782K 0.14% 209
2020
Q2
Sell
-4
Closed 476
2020
Q1
$0 Buy
+4
New +$347 ﹤0.01% 631
2019
Q3
Sell
-408
Closed -$27K 477
2019
Q2
$27K Buy
+408
New +$23.5K 0.17% 176
2019
Q1
Sell
-400
Closed -$21K 606
2018
Q4
$21K Buy
+400
New +$22K 0.1% 277

Other funds holding MEDP

Pearl River Capital's MEDP Position: Q3 2024 in Review

Pearl River Capital sold out of Medpace (MEDP) in Q3 2024, closing a stake of 9,519 shares — an estimated $3.92M sold.

Pearl River Capital first reported a position in MEDP in Q4 2018 and held it in 11 quarters. The position peaked at $3.92M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Pearl River Capital reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Pearl River Capital sold 9,519 Medpace shares in Q3 2024, an estimated $3.92M.
  • Pearl River Capital first reported a position in Medpace in Q4 2018 and held it in 11 quarters.
  • Pearl River Capital's Medpace position peaked at $3.92M in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.